Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
11.43B | 9.90B | 10.05B | 10.93B | 7.98B | Gross Profit |
5.75B | 4.32B | 4.60B | 6.23B | 3.28B | EBIT |
5.55B | 4.19B | 4.44B | 6.07B | 3.12B | EBITDA |
6.54B | 5.12B | 5.23B | 6.86B | 3.89B | Net Income Common Stockholders |
3.38B | 2.43B | 2.64B | 3.40B | 1.57B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.50B | 1.75B | 2.28B | 3.49B | 2.59B | Total Assets |
18.71B | 16.73B | 17.28B | 18.30B | 16.67B | Total Debt |
1.24B | 7.03B | 7.10B | 7.39B | 7.45B | Net Debt |
-2.02B | 5.88B | 5.03B | 4.39B | 5.27B | Total Liabilities |
9.48B | 9.24B | 9.13B | 10.09B | 9.39B | Stockholders Equity |
9.17B | 7.42B | 8.08B | 8.15B | 7.22B |
Cash Flow | Free Cash Flow | |||
4.42B | 2.56B | 1.85B | 3.40B | 2.19B | Operating Cash Flow |
4.42B | 3.57B | 2.80B | 4.29B | 2.78B | Investing Cash Flow |
-673.30M | -1.40B | -666.80M | -972.90M | -915.80M | Financing Cash Flow |
-1.65B | -3.10B | -3.01B | -2.48B | -1.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $39.15B | 6.66 | 16.72% | 8.18% | -8.71% | -22.75% | |
74 Outperform | $97.72B | 8.01 | 20.93% | 6.98% | -0.81% | 14.59% | |
70 Outperform | $67.38B | 19.70 | 40.71% | 2.27% | 15.54% | 39.64% | |
70 Outperform | $117.17B | 10.33 | 26.13% | 5.30% | -3.15% | 54.08% | |
66 Neutral | $47.93B | 25.59 | 10.92% | 1.80% | 10.71% | 1.94% | |
66 Neutral | $61.53B | 19.10 | 11.13% | 1.83% | 58.27% | ― | |
48 Neutral | $1.92B | -1.99 | -22.85% | 3.95% | 0.94% | -27.31% |